The next Biosynex dividend is expected to go ex in 7 months and to be paid in 8 months.
The previous Biosynex dividend was 200¢ and it went ex 5 months ago and it was paid 5 months ago.
There is typically 1 dividend per year (excluding specials), and the dividend cover is approximately 2.0.
|Summary||Previous dividend||Next dividend|
|Per share||200¢||Sign Up Required|
|Declaration date||25 Mar 2022 (Fri)||24 Mar 2023 (Fri)|
|Ex-div date||16 May 2022 (Mon)||15 May 2023 (Mon)|
|Pay date||18 May 2022 (Wed)||17 May 2023 (Wed)|
Enter the number of Biosynex shares you hold and we'll calculate your dividend payments:
Sign up for Biosynex and we'll email you the dividend information when they declare.
Add Biosynex to receive free notifications when they declare their dividends.
Your account is set up to receive Biosynex notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|Forecast||Final||21 Mar 2025||12 May 2025||14 May 2025||EUR||Sign up||—|
|Forecast||Final||22 Mar 2024||13 May 2024||15 May 2024||EUR||Sign up||—|
|Forecast||Final||24 Mar 2023||15 May 2023||17 May 2023||EUR||Sign up||—|
|Paid||Final||25 Mar 2022||16 May 2022||18 May 2022||EUR||—||200¢|
|Paid||Final||25 Mar 2021||26 May 2021||28 May 2021||EUR||—||20¢|
|2022||Sign Up Required|
|2023||Sign Up Required|
|2024||Sign Up Required|
Biosynex Optimized Dividend Chart
Biosynex SA is a France-based company that specializes in the research, development and manufacture of in-vitro diagnostic kits aimed at health professionals. The Company’s products are used by biological and analytical services laboratories, obstetric units and emergency units, as well as in medical resource-limited settings. Biosynex SA specializes in four fields: tropical diseases, emergency markers, infectious diseases and autoimmunity. The Company’s products include Amnioquick (Obstetrics); Immunoquick Malaria Falciparum and Immunoquick Malaria +4 (Parasitology); Immunoquick Elifa HSV IGG, Immunoquick Elifa EBV G and Immunoquick Mono (Virology); Immunoquick Filtration CELIAC IgA and Immunoquick TG (Autoimmunology); and Immunoquick Tetanus (Bacteriology). It operates through Fumouze Diagnostics and SR2B.
- Pharmaceuticals & Biotechnology
- Share Price
- €13.17 (yesterday's closing price)
- Shares in Issue
- 10 million
- Market Cap
- Market Indices